Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Operating Income Loss of -$4.23 million for the year ending 2025.
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +64.4% in Operating Income Loss from 2024 to 2025.
- This data is from NEUROONE MEDICAL TECHNOLOGIES Corp's annual report (Form 10-K), filed with the SEC on December 17, 2025.
- XBRL data for this metric is available from 2013 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2013 to 2025), NEUROONE MEDICAL TECHNOLOGIES Corp's Operating Income Loss has declined by 16,743.2%.
- Historical annual values: Fiscal year 2025: -$4.23 million | Fiscal year 2024: -$11.89 million | Fiscal year 2023: -$11.96 million | Fiscal year 2022: -$10.03 million | Fiscal year 2021: -$10.22 million | Fiscal year 2020: -$4.90 million | Fiscal year 2019: -$5.81 million | Fiscal year 2016: -$32.6 thousand | Fiscal year 2015: -$30.9 thousand | Fiscal year 2014: -$35.9 thousand | Fiscal year 2013: -$25.1 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: